KAZALD1 and malignant pleural mesothelioma: The gene product of KAZALD1 is identified as a serum biomarker in gastric cancer, and is found hypermethylated in malignant pleural mesothelioma, while low levels of DNA methylation are found associated with longer survival [31,32].